ACTG
Acacia Research Corporation
ACTG has slightly lower modeled downside risk, despite its lower overall score.
BA
The Boeing Company
BA has a slight edge over ACTG overall, supported by stronger fundamentals and stronger modeled upside.
ACTG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Strong |
ACTG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ACTG PE Valuation
ACTG has no meaningful PE right now: it lost money over the past year.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
ACTG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ACTG's losses to shrink, with revenue growing.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
ACTG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.19 | -480% |
| Q2 2026 | -$0.16 | -$0.10 |
| Q1 2026 | -$0.19 | -$0.08 |
| Q4 2025 | $0.22 | +$0.58 |
| Q3 2025 | $0.05 | -94% |
| Q2 2025 | -$0.06 | -106% |
| Q1 2025 | -$0.11 | -117% |
| Q4 2024 | -$0.36 | -162% |
ACTG has swung to a loss: it lost $0.19 per share over the past year, after a profit the year before.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over ACTG on earnings quality, reporting a profit while its opponent remains loss making.
ACTG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.4M | -8.4% |
| Q2 2026 | $114.6M | +124% |
| Q1 2026 | $54.2M | -56% |
| Q4 2025 | $50.1M | +2.6% |
| Q3 2025 | $59.4M | +155% |
| Q2 2025 | $51.2M | +98% |
| Q1 2025 | $124.4M | +412% |
| Q4 2024 | $48.8M | -47% |
ACTG's revenue fell from its 2025 peak and has held roughly level since: $54M last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.6% | +4.2 points |
| Q2 2026 | 7.4% | +32 points |
| Q1 2026 | -15% | -46 points |
| Q4 2025 | -26% | +6.3 points |
| Q3 2025 | -11% | +33 points |
| Q2 2025 | -24% | -5.8 points |
| Q1 2025 | 31% | +39 points |
| Q4 2024 | -32% | -95 points |
ACTG's operating margin was −6.6% last quarter, up 4.2 points from the same quarter a year ago.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over ACTG on profitability, with a higher operating margin.
ACTG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15M | +57% |
| Q2 2026 | $3.9M | -92% |
| Q1 2026 | $3.4M | +916% |
| Q4 2025 | $13.2M | +$36.7M |
| Q3 2025 | $9.5M | +$12.4M |
| Q2 2025 | $50.1M | +$176.9M |
| Q1 2025 | $335K | -99% |
| Q4 2024 | -$23.6M | -$19M |
ACTG generated $35M in free cash flow over the past year, down 2.8% from the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over ACTG on cash flow, with more consistent year-over-year improvement.
ACTG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -531K shares |
| 1 year | +1.2% | +1.1M shares |
| 3 years | -1.5% | -1.5M shares |
| 5 years | +101% | +49M shares |
| Available history | +79% | +43.2M shares |
ACTG has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | $13M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $11.5M |
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
ACTG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -15.9x | Net Cash |
| Q2 2026 | -12.8x | Net Cash |
| Q1 2026 | -222.7x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -4.9x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -246.8x | Net Cash |
ACTG has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
ACTG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 22.5 | Neutral |
ACTG's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ACTG PE vs Industrials Sector
| Metric | ACTG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ACTG has no meaningful PE right now: it lost money over the past year.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
ACTG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.26 | 2.3% below |
| 20 week MA | $4.44 | 6.3% below |
| 50 week MA | $4.41 | 5.7% below |
| 100 week MA | $4.04 | 3% above |
| 200 week MA | $4.19 | 0.7% below |
ACTG has the edge over BA on trend strength, trading above more of its moving averages.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ACTG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.67 | $4.10 | +54% |
| 2021 | $4.10 | $5.23 | +28% |
| 2022 | $5.23 | $3.98 | -24% |
| 2023 | $3.98 | $3.92 | -1.5% |
| 2024 | $3.92 | $4.37 | +11% |
| 2025 | $4.37 | $3.73 | -15% |
| 2026 YTD | $3.73 | $4.16 | +12% |
ACTG has the edge over BA on returns for 2026, with the stronger performance.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.